Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Harvard Business School
McKesson
AstraZeneca
Boehringer Ingelheim

Last Updated: January 27, 2023

Technetium tc-99m tilmanocept - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for technetium tc-99m tilmanocept and what is the scope of freedom to operate?

Technetium tc-99m tilmanocept is the generic ingredient in one branded drug marketed by Cardinal Health 414 and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Technetium tc-99m tilmanocept has thirty patent family members in twelve countries.

One supplier is listed for this compound.

Summary for technetium tc-99m tilmanocept
International Patents:30
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 7
DailyMed Link:technetium tc-99m tilmanocept at DailyMed
Recent Clinical Trials for technetium tc-99m tilmanocept

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
John O. PriorEarly Phase 1
Eben RosenthalPhase 2
National Cancer Institute (NCI)Phase 2

See all technetium tc-99m tilmanocept clinical trials

US Patents and Regulatory Information for technetium tc-99m tilmanocept

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cardinal Health 414 LYMPHOSEEK KIT technetium tc-99m tilmanocept INJECTABLE;INJECTION 202207-001 Mar 13, 2013 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cardinal Health 414 LYMPHOSEEK KIT technetium tc-99m tilmanocept INJECTABLE;INJECTION 202207-001 Mar 13, 2013 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cardinal Health 414 LYMPHOSEEK KIT technetium tc-99m tilmanocept INJECTABLE;INJECTION 202207-001 Mar 13, 2013 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for technetium tc-99m tilmanocept

Country Patent Number Title Estimated Expiration
Japan 2017066148 ジエチレントリアミン五酢酸(DTPA)−デキストランを放射標識するための組成物 (COMPOSITION FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN) See Plans and Pricing
Japan 6833892 See Plans and Pricing
European Patent Office 3884965 COMPOSITIONS DE RADIOMARQUAGE DE L'ACIDE DIÉTHYLÈNETRIAMINEPENTAACÉTIQUE (DTPA)-DEXTRAN (COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN) See Plans and Pricing
Australia 5270500 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for technetium tc-99m tilmanocept

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1178838 15C0033 France See Plans and Pricing PRODUCT NAME: TILMANOCEPT; REGISTRATION NO/DATE: EU/1/14/955 20141121
1178838 122015000033 Germany See Plans and Pricing PRODUCT NAME: TILMANOCEPT; REGISTRATION NO/DATE: C(2014) 8901 FINAL 20141119
1178838 1590025-1 Sweden See Plans and Pricing PRODUCT NAME: TILMANOCEPT; REG. NO/DATE: EU/1/14/955 20141120
1178838 300736 Netherlands See Plans and Pricing PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Colorcon
Moodys
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.